S. Yamaguchi

A retrospective study evaluating efficacy and safety of compassionate use of tocilizumab in 13 patients with severe-to-critically ill COVID-19: analysis of well-responding cases and rapidly-worsening cases after tocilizumab administration

K. Uno, T. Hirashima, H. Matsuoka, 2020, medRxiv.

Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation

H. Braun, R. Hirose, P. Stock, 2022, Frontiers in Surgery.

Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study

Toshio Tanaka, Hidekazu Suzuki, T. Hirashima, 2020, Journal of Infection and Chemotherapy.

Prompt Reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19

Toshio Tanaka, T. Shioda, K. Yoshizaki, 2021, Frontiers in Medicine.

Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma

N. Nonomura, M. Uemura, W. Nakata, 2021, AntiCancer Research.

Nodular Regenerative Hyperplasia After Liver Transplant; It’s All in the Presentation

H. Braun, J. Roberts, R. Dirks, 2022, Frontiers in Surgery.